Detalhe da pesquisa
1.
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
J Infect Dis
; 214(suppl 3): S210-S217, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587634
2.
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
J Infect Dis
; 214(suppl 3): S203-S209, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521365
3.
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.
J Infect Dis
; 214(suppl 3): S110-S121, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402779
4.
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
Sci Rep
; 8(1): 5939, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29651117
5.
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.
Nat Med
; 23(10): 1146-1149, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869611
6.
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
Antiviral Res
; 133: 218-222, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531367
7.
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
Nat Commun
; 7: 11544, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27161536
8.
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak.
Science
; 345(6202): 1369-72, 2014 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214632